MedTrace Logo

Comparative Safety and Efficacy of Two Treatments in the Treatment of Acne Vulgaris

NCT02515305 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 890

Last updated 2021-11-08

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare the safety and efficacy of Perrigo's product to an FDA approved product for the treatment acne vulgaris

Conditions

Interventions

DRUG

Clindamycin and Benzoyl Peroxide Gel (combination)

DRUG

Clindamycin and Benzoyl Peroxide Gel (Reference) (combination)

DRUG

Placebo gel (combination)

Sponsors & Collaborators

  • Padagis LLC

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2016-04-30
Completion
2016-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02515305 on ClinicalTrials.gov